Fenofibric Acid
Links shared publicly online about this topic
Cardiology Medical News about Dyslipidemias Fenofibric acid
mdlinx.com — “Fenofibric acid: a new fibrate approved for use in combination with statin for the treatment of mixed dyslipidemia” View full resource at mdlinx.com
Most Recently Shared on May 18, 2010 at 6:26 pm By:
Sandeep Pulim MD Doctor, Health Communicator, and Physician
Fenofibric acid: a new fibrate approved for use in combination with statin for the treatment of mix... http://bit.ly/bHC13O #cardio #mdlinx
FDA panel to vote on efficacy, safety of fenofibric acid
endocrinetoday.com — “The FDA Endocrinologic and Metabolic Drugs Advisory Committee will today discuss the future of fenofibric acid. The panel is expected to vote w” View full resource at endocrinetoday.com
Most Recently Shared on May 19, 2011 at 2:14 pm By:
Today the FDA panel will vote on safety, efficacy of fenofibric acid. http://bit.ly/iSNdGM Stay tuned for the results!
Family Med Medical News about Dyslipidemias Fenofibric acid
mdlinx.com — “Fenofibric acid: a new fibrate approved for use in combination with statin for the treatment of mixed dyslipidemia” View full resource at mdlinx.com
Most Recently Shared on May 19, 2010 at 12:12 am By:
Sandeep Pulim MD Doctor, Health Communicator, and Physician
Fenofibric acid: a new fibrate approved for use in combination with statin for the treatment of mixed d... http://bit.ly/bU8lca #GM #mdlinx
FDA panel advises clinical trial, revised labeling of fenofibric acid
endocrinetoday.com — “The FDA Endocrinologic and Metabolic Drugs Advisory Committee unanimously recommended a clinical trial to assess the cardiovascular benefits of adding” View full resource at endocrinetoday.com
Most Recently Shared on May 19, 2011 at 8:34 pm By:
The votes are in! #FDA panel advises clinical trial, revised labeling of #fenofibric acid http://bit.ly/iJ0ViM
Abbott And AstraZeneca Extend Relationship To Include Co-promotion Of TRILIPIX(R) (fenofibric Acid)
medicalnewstoday.com — “Abbott and astrazeneca announced today that they have entered into an agreement for astrazeneca to co-promote abbott's trilipix® (fenofibric acid), a medication for use alone or in combinatio” View full resource at medicalnewstoday.com
Most Recently Shared on June 10, 2009 at 11:45 pm By:
MedicalNewsToday: Abbott And AstraZeneca Extend Relationship To Include: http://tinyurl.com/lzkkyz Full http://tinyurl.com/llxvg9
Efficacy of Fenofibric Acid Plus Statins on Multiple Lipid Parameters and Its Safety in Women With Mixed Dyslipidemia
peerview-institute.org — “Efficacy of Fenofibric Acid Plus Statins on Multiple Lipid Parameters and Its Safety in Women With Mixed Dyslipidemia” View full resource at peerview-institute.org
Most Recently Shared on January 26, 2011 at 3:04 am By:
James Underberg Internist, Physician, and Doctor
Efficacy of #Fenofibric Acid & #Statins on Multiple 3Lipid Parameters and Its Safety in Women With Mixed #Dyslipidemia http://goo.gl/HsDna
Medical News: Fenofibric Acid May Not Cut Cardiac Risk, FDA Warns - in Cardiovascular, Dyslipidemia from MedPage Today
medpagetoday.com — “The FDA has ordered that the label for fenofibric acid (Trilipix) be changed to indicate that the lipid-lowering drug has not been shown to reduce the risk of heart attack or stroke.” View full resource at medpagetoday.com
Most Recently Shared on November 9, 2011 at 6:04 pm By:
FDA ordered the label for fenofibric acid to indicate that it hasn't shown to reduce risk of heart attack & stroke http://t.co/ug89saXQ
FDA Panel to Vote on Revoking Approval for Fenofibrate - QualityPoint Technologies
qualitypointtech.net — “WASHINGTON (MedPage Today) -- The FDA will ask a panel of cardiovascular experts whether it should revoke approval for Abbott's fenofibric acid (Trilipix) in light of findings from the ACCORD-Lipid trial that called into question the efficacy of using the heart drug as an add-on to statin therapy.” View full resource at qualitypointtech.net
Most Recently Shared on May 17, 2011 at 9:45 pm By:
FDA Panel to Vote on Revoking Approval for Fenofibrate: WASHINGTON (MedPage Today) -- The FDA will ask a panel of ... http://bit.ly/jEcRCD
Medical News: FDA Panel to Vote on Revoking Approval for Fenofibrate - in Cardiovascular, Dyslipidemia from MedPage Today
medpagetoday.com — “WASHINGTON -- The FDA will ask a panel of cardiovascular experts whether it should revoke approval for Abbott's fenofibric acid (Trilipix) in light of findings from the ACCORD-Lipid trial that called” View full resource at medpagetoday.com
Most Recently Shared on May 18, 2011 at 2:52 pm By:
HealthTrendster Health Executive
FDA Panel to Vote on Revoking Approval for Fenofibrate: WASHINGTON (MedPage Today) -- The FDA… http://goo.gl/fb/lXae1
Fenofibrate Use Soars Despite Lack of Benefit (CME/CE) - QualityPoint Technologies
qualitypointtech.net — “(MedPage Today) -- Prescriptions for fenofibrate (TriCor) and fenofibric acid (Trilipix) tripled from 2002 to 2009 -- even as clinical studies failed to confirm that they reduce cardiovascular events in diabetic patients, researchers said.” View full resource at qualitypointtech.net
Most Recently Shared on March 22, 2011 at 9:00 pm By:
Fenofibrate Use Soars Despite Lack of Benefit (CME/CE): (MedPage Today) -- Prescriptions for fenofibrate (TriCor) ... http://bit.ly/iaruxW
Companies ask FDA to approve Crestor-Trilipix combo pill
theheart.org — “If the agency agrees, the companies will market the new drug as Certriad.” View full resource at theheart.org
Most Recently Shared on June 8, 2009 at 8:59 pm By:
heartwire: AstraZeneca, Abbott ask the FDA to approve Crestor-Trilipix combo pill http://bit.ly/qSacl
Cardiology Medical News about Dyslipidemia
mdlinx.com — “The Effects of Fenofibric Acid Alone and With Statins on the Prevalence of Metabolic Syndrome and its Diagnostic Components in Patients With Mixed Dyslipidemia” View full resource at mdlinx.com
Most Recently Shared on July 2, 2010 at 9:58 am By:
Sandeep Pulim MD Doctor, Health Communicator, and Physician
The Effects of Fenofibric Acid Alone and With Statins on the Prevalence of Metabolic Syndrome and i... http://bit.ly/bae3xd #cardio #mdlinx
Internal Medicine Article | Dyslipidemias
mdlinx.com — “Efficacy and Safety of Rosuvastatin 5 mg in Combination with Fenofibric Acid 135 mg in Patients with Mixed Dyslipidemia " A Phase 3 Study” View full resource at mdlinx.com
Most Recently Shared on November 3, 2010 at 12:29 pm By:
Sandeep Pulim MD Doctor, Health Communicator, and Physician
Efficacy and Safety of Rosuvastatin 5 mg in Combination with Fenofibric Acid 135 mg in Patients with Mixe... http://bit.ly/asnK04 #medicine
Internal Medicine Article | Dyslipidemias
mdlinx.com — “Efficacy of Fenofibric Acid Plus Statins on Multiple Lipid Parameters and Its Safety in Women With Mixed Dyslipidemia” View full resource at mdlinx.com
Most Recently Shared on March 18, 2011 at 11:42 am By:
Sandeep Pulim MD Doctor, Health Communicator, and Physician
Efficacy of Fenofibric Acid Plus Statins on Multiple Lipid Parameters and Its Safety in Women With Mix... http://bit.ly/fHPydt #medicine
Cardiology Article | Dyslipidemias
mdlinx.com — “Efficacy of Fenofibric Acid Plus Statins on Multiple Lipid Parameters and Its Safety in Women With Mixed Dyslipidemia” View full resource at mdlinx.com
Most Recently Shared on March 21, 2011 at 10:04 am By:
Sandeep Pulim MD Doctor, Health Communicator, and Physician
Efficacy of Fenofibric Acid Plus Statins on Multiple Lipid Parameters and Its Safety in Women With M... http://bit.ly/dLFIAe #cardiology
The Top 3 resources shared on this topic. More resources.
Key stats and trends about this topic
Featuring the top 3 experts for this topic
-
Sandeep Pulim MD
Over 2K medical journal articles & health news summarized and delivered FREE to 35 specialties daily. Oncology, Rheumatology, Cardiology, Neurology, Psychiatry
-
Endocrine Today
The official Twitter for Endocrine Today, clinical news on diabetes and endocrine disorders.
-
Sandeep Pulim MD
Over 2K medical journal articles & health news summarized and delivered FREE to 35 specialties daily. Oncology, Rheumatology, Cardiology, Neurology, Psychiatry
Advertisement
